Shuttle Pharmaceuticals Holdings (SHPH) Profit After Tax (2021 - 2026)

Shuttle Pharmaceuticals Holdings' Profit After Tax history runs 6 years deep, the most recent figure standing at -$2.2 million for Q1 2026.

• On a quarterly basis, Profit After Tax rose 29.5% year-over-year to -$2.2 million in Q1 2026; TTM through Mar 2026 was -$10.8 million, a 3.39% decrease from a year earlier, with the FY2025 full-year figure at -$11.7 million, down 28.18% from the prior year.
• Profit After Tax improved to -$2.2 million in Q1 2026 per SHPH's latest filing, from -$2.6 million in the prior quarter.
• Across five years, Profit After Tax topped out at -$597275.0 in Q2 2022 and bottomed at -$3.8 million in Q3 2024.
• The 5-year median for Profit After Tax is -$1.8 million (2023), against an average of -$1.9 million.
• Across the five-year window, Profit After Tax sank 360.19% in 2022 and soared 37.97% in 2025, its largest moves.
• Year by year, Profit After Tax stood at -$750909.0 in 2022, then tumbled by 118.47% to -$1.6 million in 2023, then climbed by 2.56% to -$1.6 million in 2024, then tumbled by 63.59% to -$2.6 million in 2025, then gained by 17.68% to -$2.2 million in 2026.
• Per Business Quant, the three latest SHPH Profit After Tax figures stand at -$2.2 million (Q1 2026), -$2.6 million (Q4 2025), and -$2.3 million (Q3 2025).